Research & Development Services
Complementary Research & Development areas of expertise in immunology. Accelerating target identification, product validation and beyond. Delivering first-in-class therapies activating and regulating the immune system.
-
Most popular related searches
Identification of New Targets
OSE Immunotherapeutics’ integrated Research & Development engine focuses on developing innovative immunotherapies for immune regulation in the fields of immuno-oncology and autoimmune diseases. It is based on three areas of expertise in immunology:
Immuno-Oncology: focused on myeloid targets, Auto-Immunity & Inflammation, T-cell-based vaccination.
Building on unparalleled experience in clinical immunology initially applied to transplantion, OSE’s research benefits from a fully translational platform fully intertwined with academic centers with complementary expertise in immunotherapy (INSERM, Center for Research in Transplantation and Immunology, University Hospital of Nantes, etc.).
Leveraging these collaborations and in-house expertise on novel target discovery, OSE’s team identifies innovative agonists or antagonists of the immune response and generates viable therapeutics using the following technological platforms: optimized neo-epitopes, myeloid checkpoint inhibitors, monoclonal antibodies, and bispecific antibodies.
Customer reviews
No reviews were found for Research & Development Services. Be the first to review!